News and Media

MMS ANNOUNCES ONE MILLION DOLLAR AWARD FOR PHARMACEUTICAL COMPANIES DEVELOPING A VACCINE FOR COVID-19

Canton, Mich. (March 20, 2020) — MMS Holdings announced today that it is offering a USD1M award toward the development of a vaccine for COVID-19, also known as the coronavirus. The award is being offered in the form of data and related services to qualified pharmaceutical and clinical research companies supporting the commercial development of a vaccine for approval in the United States and/or other global health authorities.

Committed to the health of your projects during COVID-19

by Prasad M. Koppolu, March 12, 2020
I would like to take a moment and share our commitment to the highest levels of health and improving lives worldwide, amidst the outbreak of COVID-19.

MMS HOLDINGS TO DEBUT DATACISE INTEGRATED SAFETY EXPLORER TO DETECT SAFETY SIGNALS USING REAL-WORLD EVIDENCE DURING PHUSE/FDA DATA SCIENCE INNOVATION CHALLENGE

CANTON, Mich. (March 4, 2020) – MMS Holdings (MMS) – an award-winning, data-focused CRO – announced today that the Datacise Integrated Safety Explorer will make its debut at the 2020 PHUSE U.S. Connect conference in Orlando, Florida as part of the PHUSE/FDA Data Science Innovation Challenge, where, according to PHUSE, the “greatest minds in the data sciences arena come together and collaborate.”

MMS HOLDINGS DOUBLES GROWTH IN SOUTH AFRICA REGION AMID BURGEONING PHARMACEUTICAL INDUSTRY LOCALLY

BLOEMFONTEIN, South Africa (November 20, 2019) – MMS Holdings (MMS) – an award-winning, data-focused CRO – announced today that its regional operations in South Africa has more than doubled in the past fiscal year, through the addition of new colleagues in Bloemfontein and the successful procurement of key contracts with clinical trial sponsors and research groups.

MMS HOLDINGS EXECUTIVE MICHELLE GAYARI JOINS ADVISORY BOARD OF INTERNATIONAL NONPROFIT THAT PROVIDES EDUCATIONAL PROGRAMS TO CHILDREN IN HOSPITALS

CANTON, Mich. (October 23, 2019) – MMS Holdings – an award-winning, data-focused CRO – announced today that its Executive Director of Global Operations Michelle Gayari has joined the advisory board for the international 501(c)(3) charity Together Educating All Children in Hospitals (TEACH). As its sole board member in the state of Michigan, Gayari will provide leadership, guidance, and fundraising support to help in bringing exciting, hands-on educational programs to children in hospitals.

MMS HOLDINGS ANNOUNCES STATUS AS A FINALIST FOR BEST CONTRACT RESEARCH ORGANIZATION – SPECIALIST PROVIDERS IN SCRIP AWARDS DURING 10TH ANNUAL SCIENTIFIC SYMPOSIUM

CANTON, Mich. (October 10, 2019) – MMS Holdings (MMS) – an award-winning, data-focused CRO – announced its recognition as a finalist in the highly-esteemed, global Scrip Awards by Informa Pharma Intelligence as Best Contract Research Organization – Specialist Providers at the 10th Annual MMS Scientific Symposium.

Oracle Health Sciences and MMS Collaborate to Deliver Complex Database Build for Oncology Sponsor

CANTON, Mich. (September 30, 2019) – MMS Holdings (MMS) – an award-winning, data-focused CRO – celebrated another successful collaboration with Oracle Health Sciences and a specialized Oncology pharmaceutical company. MMS will share their learnings with peers at the Society for Clinical Data Management (SCDM) annual meeting in Baltimore, Md.

MMS HOLDINGS NAMED HONORABLE MENTION IN PRESTIGIOUS PR DAILY CORPORATE SOCIAL RESPONSIBILITY AWARDS FOR #ONEMMS VOLUNTEER INITIATIVE

CANTON, Mich. (September 10, 2019) – MMS Holdings (MMS) – an award-winning, data-focused CRO – was recently announced as an honorable mention recipient of PR Daily’s Corporate Social Responsibility Awards in the Engagement & Communications category for its #OneMMS volunteer campaign.

MMS Holdings and Sage IT Celebrate 10-Year Relationship with Deep Focus on Intelligent Automation and Bot Development

CANTON, Mich. and FRISCO, Texas (August 1, 2019) – MMS Holdings – an award-winning, data-focused CRO – announced that today marks 10 years of successful partnership with Sage IT—a premier provider, helping companies operationalize their vision through the enhancement or development of innovative technology solutions.

MMS Holdings Launches New Time-Saving Application to Automatically Perform Quality Control and Style Checks for Medical Writers

CANTON, Mich. (June 27, 2019) – MMS announced today the launch of Automatiqc™ (pronounced: automatic). Automatiqc is a new cloud-based application that automatically performs quality control (QC) and style checks for medical writing, pharmacovigilance, clinical trial transparency, and other types of documents in the pharmaceutical, biotechnology, and medical device industries.